Serum albumin at 1 Year Predicts Long-term CAPD Outcomes

Among 436 patients using CAPD and followed for at least a year (48.25 + 24.05 months), each 1 g/dL increase in serum albumin at 1 year after PD start reduced the risk of death by 8.7%.

Read the abstract » | (added 2022-12-19)

Tags: Peritoneal Dialysis , Serum Albumin, CAPD, Mortality

The Predictive Value of Early, Non-infectious PD Complications

A prospective, multicenter cohort study of 1,596 people starting PD in New Zealand from 2014 to 2018 (inclusive) looked at survival and time on PD of those who had catheter-related exit site dialysate leaks or other leaks within 30 days of PD start. Peritonitis-free survival, first PD catheter survival, and tunnel infection free survival were secondary outcomes. Among the 102 with an early complication, overall mortality, the rate of stopping PD, and first catheter failure were all higher.

Read the abstract » | (added 2022-11-16)

Tags: PD, Survival, Peritonitis free Survival, First PD Catheter Survival, Tunnel Infection Free Survival, Early Catheter related Complication

Spiritual Well-being and PD Outcomes

The Peritoneal Dialysis Outcomes and Practice Patterns (PDOPPS) study has looked at whether spiritual well-being (SWB) affects PD outcomes, using a survey of SWB and SF-12 results. Among 529 people on PD who completed the surveys, 70% had moderate or higher SWB scores, which were positively correlated with higher physical and mental functioning and burden of kidney disease scores, and linked with less likelihood of depression.

Read the abstract » | (added 2022-07-13)

Tags: Peritoneal Dialysis Outcomes, PDOPPS, Spiritual Well being, SWB

Home Dialysis Associated with Higher Patient Activation

Increased patient activation is linked with better health outcomes. Among 182 people starting dialysis who took the Patient Activation Measure (PAM) survey at month 1 and month 4, those who did home dialysis tended to have higher PAM scores than those who did in-center treatments.

Read the abstract » | (added 2022-07-13)

Tags: Patient Activation, Health Outcomes, Dialysis, Patient Activation Measure, PAM, Home Dialysis

In Which Countries Do People Stay on PD Longer?

The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) analyzed time on PD among 218 randomly chosen clinics and 7,121 patients in seven countries including the U.S. Median time on PD ranged from 1.7 years in the UK to 3.2 years in Japan and Thailand. PD mortality risk was higher in Thailand and the U.S., and infection was the leading cause of transfers to HD.

Read the abstract » | (added 2022-06-10)

Tags: Peritoneal Dialysis Outcomes And Practice Patterns Study, PDOPPS, PD, Mortality, Hemodialysis Transfer, Kidney Transplantation

Platelet-to-Albumin Ratio Predicts PD Technique Success and Survival

Dividing patients’ absolute platelet counts by their serum albumin levels creates a protein-to-albumin ratio (PAR) that predicts PD outcomes, finds a new study of 405 people over a median of 2 years. Patients with lower PAR levels had higher rates of PD success and better survival.

Read the abstract » | (added 2021-12-16)

Tags: Platelet to albumin Ratio, Technique Failure, Mortality, Peritoneal Dialysis

New Clinical Practice Guidelines for Exercise on PD

The International Society for Peritoneal Dialysis and the Global Renal Exercise Network have teamed up to grade and review the literature and clinical experience to help people on PD stay physically active safely. With sparse quality evidence available, the new guidelines are largely opinion based, and cover timing of exercise relative to PD (i.e., empty or full); impact of exercise on mental health, weight, frailty, etc.; exercise nutrition, and potential adverse PD outcomes.

Read the abstract » | (added 2021-11-12)

Tags: Peritoneal Dialysis, Exercise, Physical Activity, PD Outcomes

NxStage Outcomes in Spain

The first 86 NxStage users in 12 Spanish dialysis clinics received an adequate dialysis dose, optimal ultrafiltration, improved biochemical markers, and reduced need for antihypertensive drugs, binders, and erythropoietin. Patient and technique survival were both good.

Read the abstract » | (added 2021-09-14)

Tags: Adequate Dialysis Dose, Optimal Ultrafiltration, Biochemical Markers, Antihypertensive Drugs, Binders, Erythropoietin. Patient Survival, Technique Survival

Outcomes of Incremental PD

A retrospective cohort study looked at 175 PD patients followed for about 2 years. Starting PD with a lower vs. higher dose was associated with better survival.

Read the abstract » | (added 2021-08-12)

Tags: Peritoneal Dialysis , PD, End stage Kidney Disease, Dialysate Volume, Survival

PD vs. Standard In-Center HD for Stroke Risk: A 14-year Study

Of 7,916 ESRD patients with atrial fibrillation between 2001 and 2013, data from 363 PD and 5,302 HD patients were analyzed. At 1 year, 3 years, and 5 years, the participants who used PD had significantly lower risks for outcomes including stroke, major bleeding, and intracranial hemorrhage than those using HD.

Read the abstract » | (added 2021-06-15)

Tags: ESRD, End Stage Renal Disease, Atrial Fibrillation, Peritoneal Dialysis, Hemodialysis, Patient Outcomes